Experts Discuss CELMoD Agents for Treating Multiple Myeloma скачать в хорошем качестве

Experts Discuss CELMoD Agents for Treating Multiple Myeloma

In this podcast episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Niels van de Donk, MD, PhD, address key questions on CELMoD agent therapy for multiple myeloma, including: • Combination strategies • Adverse event management • Where CELMoD agents may best fit within current and future treatment strategies  Presenters:  Jesus Berdeja, MD Director of Multiple Myeloma Research Greco-Hainsworth Centers for Research Tennessee Oncology Nashville, Tennessee Amrita Krishnan, MD, FACP Director, Judy and Bernard Center for Myeloma, City of Hope Nason Hollingsworth Family Chair Myeloma Executive Director, Hematology, City of Hope Orange County Professor Hematology/HCT Irvine, California  Niels van de Donk, MD, PhD Professor of Hematology Department of Hematology Amsterdam UMC, Location VUmc Amsterdam, Netherlands Content based on an online CME program supported by an educational grant from Bristol Myers Squibb. Link to full program: https://bit.ly/4qvRwQM Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.